Maternal Use of Hydroxychloroquine is Associated with a Reduced Risk of Recurrent Anti-SSA/Ro Associated Cardiac Manifestations of Neonatal Lupus

BACKGROUND: A recent case control study suggested a benefit of hydroxychloroquine (HCQ) in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies of anti-SSA/Ro positive patients with Systemic Lupus Erythematosus (SLE). A historical cohort assembled from three inte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Izmirly, Peter M., Costedoat-Chalumeau, Nathalie, Pisoni, Cecilia, Khamashta, Munther A., Kim, Mimi Y., Saxena, Amit, Friedman, Deborah, Llanos, Carolina, Piette, Jean-Charles, Buyon, Jill P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437628/
https://ncbi.nlm.nih.gov/pubmed/22626746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.111.089268
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados